Fezolinetant cuts hot flashes for almost 6 months
Fezolinetant 45 mg appears to be effective for up to 24 weeks in the treatment of moderate-to-severe vasomotor symptoms (VMS) associated with menopause in women who are considered… read more.
Fezolinetant 45 mg appears to be effective for up to 24 weeks in the treatment of moderate-to-severe vasomotor symptoms (VMS) associated with menopause in women who are considered… read more.
A new screening algorithm for preeclampsia combining maternal history, ultrasound data and several tests for blood markers may better predict the majority of preeclampsia cases in the first… read more.
Gilead Sciences, Inc. announced the FDA approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25… read more.
Bacterial Vaginosis (BV) affects about one-quarter of reproductive-age women and is linked to adverse health outcomes, such as increased HIV risk. Yet for decades, BV treatment in the… read more.
Utility Therapeutics received approval from the FDA for Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract infections (UTIs) caused by susceptible isolates of… read more.
Deborah Evans is a pharmacist and independent prescriber who specialises in women’s reproductive and sexual health, including the menopause. She owns and runs Remedi Health, an independent pharmacy… read more.
Working in the menopause clinic is professionally rewarding and there is a wealth of resources available for keeping up-to-date. Awareness of the latest evidence and the ability to… read more.
Transdermal oestrogen products and the management of genitourinary syndrome of menopause are two important topics in menopause management. Selecting the most appropriate treatments should take into account individual… read more.
Testosterone is an important hormone for women and may need replacement alongside oestrogen and progesterone, says Deborah Evans, pharmacist prescriber and Clinic Director at Remedi Health. Replacing testosterone… read more.
The benefits of hormone replacement therapy (HRT) using transdermal devices are considerable, including a 30% reduction in all-cause mortality, according to Deborah Evans, prescribing pharmacist and Clinic Director… read more.
Deborah Evans is a pharmacist and independent prescriber who specialises in women’s reproductive and sexual health, including the menopause. She owns and runs Remedi Health, an independent pharmacy… read more.
A third of the nearly 20 million women who participated in a national health survey report migraines during menstruation, and of them, 11.8 million, or 52.5%, were premenopausal…. read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.